Factors associated with outcomes following autologous haematopoietic stem cell transplantation for multiple sclerosis
Yassine Noui(Uppsala University), Joachim Burman(Uppsala University), Thomas Silfverberg(Uppsala University), Kristina Carlson(Uppsala University Hospital), Kim Kultima(Uppsala University), Per Ljungman(Karolinska University Hospital), Christina Zjukovskaja(Uppsala University Hospital), Tobias Tolf(Uppsala University), Andreas Tolf(Uppsala University)
Cited by 5
Related Papers
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k
Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009
|Bone Marrow Transplantation|2009|385